Equity Briefing: L'Occitane, Obagi Medical, Oriflame stand out as the best personal care takeover candidates

In a report from London on Thursday, Bloomberg's Gaurav Panchal issued a report to investors in which Berenberg names L'Occitane International SA, Obagi Medical Products, Inc. (NASDAQ:OMPI) and Oriflame Cosmetics SA (OFLMY) as the listed companies most likely to attract quality bid offers. "Few Household & Personal Care offer the correct mix of scale, fit, 'buzz', synergy potential to attract interest from major industry players, Berenberg says...
Comunicato Precedente

next
Comunicato Successivo

next

In a report from London on Thursday, Bloomberg's Gaurav Panchal issued a report to investors in which Berenberg names L'Occitane International SA, Obagi Medical Products, Inc. (NASDAQ:OMPI) and Oriflame Cosmetics SA (OFLMY) as the listed companies most likely to attract quality bid offers.

"Few Household & Personal Care offer the correct mix of scale, fit, 'buzz', synergy potential to attract interest from major industry players, Berenberg says."

Earlier this week, Obagi Medical shareholders overwhelmingly voted against ratifying its Rights Plan, which was carefully considered and recommended by leading proxy advisory firm, Institutional Shareholder Services.

The move may set the table for the company to be acquired in short order.

Berenberg says the three publicly listed companies currently stand out as the best takeover candidates while Coty and Unilever are likely to remain most aggressive buyers in the space.

In mid-May, Coty Inc. withdrew a $10.7 billion offer for Avon Products Inc. (NYSE:AVP), the world's largest door-to-door cosmetics seller.



Copyright Thomson Reuters


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: %s via Thomson Reuters ONE


[HUG#1618259]
Per maggiori informazioni
Sito Web
http://

Ufficio Stampa

 Thomson Reuters (Leggi tutti i comunicati)
3 Times Square
10036 New York, NY

Allegati
Slide ShowSlide Show
Non disponibili
;